These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4550499

  • 1. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.
    Rinne UK, Sonninen V.
    Neurology; 1972 Jan; 22(1):62-7. PubMed ID: 4550499
    [No Abstract] [Full Text] [Related]

  • 2. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
    Chase RN, Schnur JA, Brody JA, Gordon EK.
    Arch Neurol; 1971 Jul; 25(1):9-13. PubMed ID: 5146413
    [No Abstract] [Full Text] [Related]

  • 3. 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
    Johansson B, Roos BE.
    Eur J Clin Pharmacol; 1971 Sep; 3(4):232-5. PubMed ID: 5151306
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous probenecid loading. Effects on plasma and cerebrospinal fluid probenecid levels and on monoamine metabolites in cerebrospinal fluid.
    Kartzinel R, Ebert MH, Chase TN.
    Neurology; 1976 Oct; 26(10):992-6. PubMed ID: 134293
    [Abstract] [Full Text] [Related]

  • 5. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
    Olsson R, Roos BE.
    Nature; 1968 Aug 03; 219(5153):502-3. PubMed ID: 5668438
    [No Abstract] [Full Text] [Related]

  • 6. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
    Korf J, van Praag HM, Schut D, Nienhuis RJ, Lakke JP.
    Eur Neurol; 1974 Aug 03; 12(5-6):340-50. PubMed ID: 4448192
    [No Abstract] [Full Text] [Related]

  • 7. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1973 Aug 03; 9(6):349-62. PubMed ID: 4712542
    [No Abstract] [Full Text] [Related]

  • 8. Central monoamine metabolism in Parkinson's disease.
    Chase TN, Ng LK.
    Arch Neurol; 1972 Dec 03; 27(6):486-91. PubMed ID: 5083866
    [No Abstract] [Full Text] [Related]

  • 9. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
    Gumpert J, Sharpe D, Curzon G.
    J Neurol Sci; 1973 May 03; 19(1):1-12. PubMed ID: 4715017
    [No Abstract] [Full Text] [Related]

  • 10. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
    van Woert MH, Bowers MB.
    Neurology; 1970 Apr 03; 20(4):377. PubMed ID: 5534981
    [No Abstract] [Full Text] [Related]

  • 11. Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism.
    Chase TN.
    Neurology; 1970 Dec 03; 20(12):Suppl:36-40. PubMed ID: 5312403
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of L-dopa on monoamine metabolites in Parkinson's disease.
    van Woert MH, Bowers MB.
    Experientia; 1970 Dec 03; 26(2):161-3. PubMed ID: 5308739
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.
    Johansson B, Roos BE.
    Life Sci; 1967 Jul 01; 6(13):1449-54. PubMed ID: 6035772
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acid monoamine metabolites in cerebrospinal fluid during methadone maintenance.
    Bowers MB, Kleber HD, Davis L.
    Nature; 1971 Aug 20; 232(5312):581-2. PubMed ID: 4937511
    [No Abstract] [Full Text] [Related]

  • 19. Clinical significance of probenecid test.
    Lakke JP, Korf J, van Praag HM, Minderhoud JM, Schut T.
    Lancet; 1973 Mar 17; 1(7803):614-5. PubMed ID: 4120687
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.